Dynavax options active into PDUFA Dynavax March 4 and 6 calls are active on total call volume of 7K contracts (3K puts). March call option implied volatility is at 217, April is at 168, July is at 119; compared to its 26-week average of 116 according to Track Data. Active option volume suggests traders taking positions for larger price movement into PDUFA Date for Heplisav on February 24.
Dynavax upgraded to Overweight from Neutral at JPMorgan JPMorgan upgraded Dynavax to Overweight saying it is now "significantly more comfortable" with the safety of the company's Heplisav vaccine for hepatitis B. The firm raised its price target for shares to $36 from $15.